DARE logo

Dare Bioscience (DARE) Accounts Payable

Annual Accounts Payable

$3.39 M
+$1.36 M+66.94%

31 December 2023

DARE Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$1.05 M
-$861.10 K-45.09%

30 September 2024

DARE Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

DARE Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+66.9%-79.0%
3 y3 years+231.5%+73.1%
5 y5 years+636.5%+197.8%

DARE Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+231.5%-84.0%+73.1%
5 y5 yearsat high+636.5%-84.0%+385.5%
alltimeall timeat high-84.0%

Dare Bioscience Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$1.05 M(-45.1%)
June 2024
-
$1.91 M(-52.7%)
Mar 2024
-
$4.04 M(+19.3%)
Dec 2023
$3.39 M(+66.9%)
$3.39 M(-32.1%)
Sept 2023
-
$4.99 M(-23.8%)
June 2023
-
$6.54 M(+142.7%)
Mar 2023
-
$2.70 M(+32.9%)
Dec 2022
$2.03 M(-3.6%)
$2.03 M(-41.7%)
Sept 2022
-
$3.48 M(+212.1%)
June 2022
-
$1.11 M(-60.6%)
Mar 2022
-
$2.83 M(+34.6%)
Dec 2021
$2.10 M(+105.9%)
$2.10 M(+247.2%)
Sept 2021
-
$605.70 K(+180.4%)
June 2021
-
$216.00 K(-85.3%)
Mar 2021
-
$1.47 M(+44.1%)
Dec 2020
$1.02 M(-5.7%)
$1.02 M(-34.3%)
Sept 2020
-
$1.56 M(-9.3%)
June 2020
-
$1.71 M(+11.9%)
Mar 2020
-
$1.53 M(+41.4%)
Dec 2019
$1.08 M
$1.08 M(+207.6%)
Sept 2019
-
$352.20 K(-44.3%)
DateAnnualQuarterly
June 2019
-
$632.10 K(+94.1%)
Mar 2019
-
$325.60 K(-29.2%)
Dec 2018
$459.70 K(+49.2%)
$459.70 K(+49.2%)
Dec 2017
$308.20 K(>+9900.0%)
$308.20 K(-63.3%)
Sept 2017
-
$839.40 K(+27.2%)
June 2017
-
$660.00 K(+2.5%)
Mar 2017
-
$644.00 K(>+9900.0%)
Dec 2016
$0.00(-100.0%)
$0.00(-100.0%)
Sept 2016
-
$1.78 M(+11.6%)
June 2016
-
$1.59 M(-27.3%)
Mar 2016
-
$2.19 M(-1.6%)
Dec 2015
$2.23 M(+77.4%)
$2.23 M(+3.2%)
Sept 2015
-
$2.16 M(+19.4%)
June 2015
-
$1.81 M(+7.5%)
Mar 2015
-
$1.68 M(+34.0%)
Dec 2014
$1.25 M(+37.3%)
$1.25 M(-14.1%)
Sept 2014
-
$1.46 M(+152.3%)
June 2014
-
$579.00 K(-73.2%)
Mar 2014
-
$2.16 M(+136.3%)
Dec 2013
$914.00 K(+1.6%)
$914.00 K
Dec 2012
$900.00 K
-

FAQ

  • What is Dare Bioscience annual accounts payable?
  • What is the all time high annual accounts payable for Dare Bioscience?
  • What is Dare Bioscience annual accounts payable year-on-year change?
  • What is Dare Bioscience quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Dare Bioscience?
  • What is Dare Bioscience quarterly accounts payable year-on-year change?

What is Dare Bioscience annual accounts payable?

The current annual accounts payable of DARE is $3.39 M

What is the all time high annual accounts payable for Dare Bioscience?

Dare Bioscience all-time high annual accounts payable is $3.39 M

What is Dare Bioscience annual accounts payable year-on-year change?

Over the past year, DARE annual accounts payable has changed by +$1.36 M (+66.94%)

What is Dare Bioscience quarterly accounts payable?

The current quarterly accounts payable of DARE is $1.05 M

What is the all time high quarterly accounts payable for Dare Bioscience?

Dare Bioscience all-time high quarterly accounts payable is $6.54 M

What is Dare Bioscience quarterly accounts payable year-on-year change?

Over the past year, DARE quarterly accounts payable has changed by -$3.94 M (-78.97%)